Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2025-03-20 00:00:00 ET · period of report 2025-03-20 · accession 0001214659-25-004592 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-20 | 2025-03-20 | ALZN | Horne William B. | Dir | P - Purchase | $0.98 | +5,000 | 26.7K | +23% | +$4,900 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-20 | P | A | 5,000 | $0.98 | 26,666 | D | — | — | (F1) The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.9783. The range of purchase prices on the transaction date was $0.974 to $0.9799 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. |